Volitionrx Ltd
VNRX- Exchange
- NYSE
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000093314
No open-market purchases or sales by Volitionrx Ltd insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Volitionrx Ltd as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −4 vs. Q1 2023
- Shares held
- 6.46M
- +47.5K (+0.7%) vs. Q1 2023
- Total value
- $8.99M
- −$3.23M (−26.4%) vs. Q1 2023
- New holders
- 2
- 8 more added
- Sold out
- 6
- 8 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VNRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 24 | $2.61M |
| Q1 2026 | 31 | $4.52M |
| Q4 2025 | 28 | $4.13M |
| Q3 2025 | 33 | $17.7M |
| Q2 2025 | 29 | $18.2M |
| Q1 2025 | 25 | $12.0M |
| Q4 2024 | 27 | $11.2M |
| Q3 2024 | 22 | $10.5M |
| Q2 2024 | 27 | $4.84M |
| Q1 2024 | 24 | $5.89M |
| Q4 2023 | 28 | $4.56M |
| Q3 2023 | 30 | $4.35M |
| Q2 2023 | 34 | $8.99M |
| Q1 2023 | 38 | $12.2M |
| Q4 2022 | 34 | $15.1M |
| Q3 2022 | 34 | $8.02M |
| Q2 2022 | 31 | $12.2M |
| Q1 2022 | 34 | $18.3M |
| Q4 2021 | 37 | $18.7M |
| Q3 2021 | 39 | $19.2M |
| Q2 2021 | 47 | $21.4M |
| Q1 2021 | 57 | $33.0M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Volitionrx Ltd; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Adirondack Retirement Specialists, Inc. | 32 | $44 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 200 | $278 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 265 | $368 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 314 | $436 | 0.00% | +40+14.6% | Added |
| Advisor Group Holdings, Inc. | 320 | $445 | 0.00% | −200−38.5% | Reduced |
| GWM Advisors LLC | 700 | $973 | 0.00% | −110−13.6% | Reduced |
| Royal Bank of Canada | 406 | $1.00K | 0.00% | +406 | New |
| Bank of America Corp | 1,000 | $1.39K | 0.00% | −60,000−98.4% | Reduced |
| National Bank of Canada | 1,000 | $1.39K | 0.00% | 00.0% | Unchanged |
| CarsonAllaria Wealth Management, Ltd. | 2,265 | $3.15K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 2,363 | $3.29K | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 2,500 | $3.48K | 0.00% | 00.0% | Unchanged |
| Founders Capital Management | 4,000 | $5.56K | 0.00% | 00.0% | Unchanged |
| Credit Agricole S A | 4,000 | $5.56K | 0.00% | 00.0% | Unchanged |
| Hartford Financial Management Inc. | 5,000 | $6.95K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 6,317 | $8.78K | 0.00% | −14,001−68.9% | Reduced |
| Sensible Money, LLC | 10,000 | $13.9K | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 10,907 | $15.2K | 0.00% | +801+7.9% | Added |
| Tower Research Capital LLC (TRC) | 12,150 | $16.9K | 0.00% | +5,903+94.5% | Added |
| Charles Schwab Investment Management Inc | 15,384 | $21.4K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 15,889 | $22.1K | 0.00% | +5,808+57.6% | Added |
| JPMorgan Chase & Co | 16,914 | $23.5K | 0.00% | −21,007−55.4% | Reduced |
| Bank of New York Mellon Corp | 21,530 | $29.9K | 0.00% | −97−0.4% | Reduced |
| DFPG Investments, LLC | 25,138 | $38.5K | 0.00% | +25,138 | New |
| Spectrum Asset Management, Inc. (NB/CA) | 55,596 | $77.3K | 0.04% | 00.0% | Unchanged |
| Northern Trust Corp | 70,092 | $97.4K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 123,923 | $172.3K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 176,100 | $244.8K | 0.01% | 00.0% | Unchanged |
| Cowen Prime Advisors LLC | 178,738 | $248.4K | 0.09% | −3,105−1.7% | Reduced |
| Morgan Stanley | 218,205 | $303.3K | 0.00% | −18,298−7.7% | Reduced |
| Geode Capital Management, LLC | 465,214 | $646.6K | 0.00% | +172,488+58.9% | Added |
| Vanguard Group Inc | 520,398 | $723.4K | 0.00% | +14,400+2.8% | Added |
| BlackRock Inc. | 568,026 | $789.6K | 0.00% | +20,218+3.7% | Added |
| Lagoda Investment Management, L.P. | 3,929,110 | $5.46M | 3.85% | +153,666+4.1% | Added |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −112,894−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −65,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −30,172−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −26,194−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −185−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |